Recently, a study confirmed the identification of CSCs and showed that PD-L1+ CSCs are strongly associated with altered T cell phenotypes and, in particular, the frequency of regulatory molecule-expressing T cells in metastatic lymph nodes of NSCLC patients (50). This evidence concerns the gene CD274 and non-small cell lung carcinoma.